Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Canova

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Future Oncology (London, England)|August 14, 2015
What are the options for non-small-cell lung cancer patients post second-line therapy?Diego Luigi Cortinovis, Stefania Canova, Paolo Bidoli
Journal of Thoracic Disease|July 26, 2017
How to describe univariate dataStefania Canova, Diego Luigi Cortinovis, Federico Ambrogi
JAMA Oncology|October 13, 2022
A Cast of Shadow on Postoperative Radiotherapy for pIIIA-N2 Non-Small Cell Lung Cancer?Stefania Canova, Stefano Arcangeli, Diego Luigi Cortinovis
Tumori|August 8, 2007
Medical treatment and other combination regimensEmilio Bajetta, Michele Del Vecchio, Roberto Bajetta, et al.
Melanoma Research|September 22, 2007
Impressive objective response in a patient with extensive metastatic melanoma including the brainMichele Del Vecchio, Stefania Canova, Antonella Messina, et al.
Tumori|October 1, 2008
Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomitingLuigi Celio, Angela Denaro, Stefania Canova, et al.
Journal of Thoracic Disease|December 31, 2015
Interpretation of lung cancer study outcomesDiego Cortinovis, Marida Abbate, Paolo Bidoli, et al.
Frontiers in Bioscience (Scholar Edition)|December 8, 2021
Anti PD-L1 antibody: is there a histologic-oriented efficacy? Focus on atezolizumab in squamous cell non-small cell lung cancerMaria Gemelli, Paolo Bidoli, Francesca Colonese, et al.
Frontiers in Medicine|December 27, 2016
Focus on Nivolumab in NSCLCDiego L Cortinovis, Stefania Canova, Marida Abbate, et al.
Journal of Visualized Surgery|October 29, 2017
A new race against lung cancerDiego Cortinovis, Stefania Canova, Mariaida I Abbate, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|August 14, 2015
What are the options for non-small-cell lung cancer patients post second-line therapy?Diego Luigi Cortinovis, Stefania Canova, Paolo Bidoli
Journal of Thoracic Disease|July 26, 2017
How to describe univariate dataStefania Canova, Diego Luigi Cortinovis, Federico Ambrogi
JAMA Oncology|October 13, 2022
A Cast of Shadow on Postoperative Radiotherapy for pIIIA-N2 Non-Small Cell Lung Cancer?Stefania Canova, Stefano Arcangeli, Diego Luigi Cortinovis
Tumori|August 8, 2007
Medical treatment and other combination regimensEmilio Bajetta, Michele Del Vecchio, Roberto Bajetta, et al.
Melanoma Research|September 22, 2007
Impressive objective response in a patient with extensive metastatic melanoma including the brainMichele Del Vecchio, Stefania Canova, Antonella Messina, et al.
Tumori|October 1, 2008
Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomitingLuigi Celio, Angela Denaro, Stefania Canova, et al.
Journal of Thoracic Disease|December 31, 2015
Interpretation of lung cancer study outcomesDiego Cortinovis, Marida Abbate, Paolo Bidoli, et al.
Frontiers in Bioscience (Scholar Edition)|December 8, 2021
Anti PD-L1 antibody: is there a histologic-oriented efficacy? Focus on atezolizumab in squamous cell non-small cell lung cancerMaria Gemelli, Paolo Bidoli, Francesca Colonese, et al.
Frontiers in Medicine|December 27, 2016
Focus on Nivolumab in NSCLCDiego L Cortinovis, Stefania Canova, Marida Abbate, et al.
Journal of Visualized Surgery|October 29, 2017
A new race against lung cancerDiego Cortinovis, Stefania Canova, Mariaida I Abbate, et al.
Pageof 5